Antimicrobial resistance (AMR) poses a greater burden in low- and middle-income countries, where obstetric and gynaecological patients frequently receive antibiotics. Specialty-level drug utilization data combined with concurrent stewardship audit are limited. This study prospectively examined antibiotic prescribing patterns, consumption metrics, and adherence to antimicrobial stewardship (AMS) recommendations among OBGYN inpatients at a public tertiary care hospital in Karachi.
A prospective cross-sectional design was used in OBGYN wards at Dow University Hospital from 1 September to 31 October 2025. Inclusion criteria were women admitted to OBGYN wards who received at least one systemic antibiotic during admission. Daily AMS rounds were conducted by an Infectious Diseases physician and a pharmacist as part of the concurrent stewardship audit.
Antibiotic consumption was measured using Defined Daily Doses (DDD) and Days of Therapy (DOT), both calculated per 1,000 patient-days. The study reported total patient-days (821) and aggregated DDD and DOT metrics. Antibiotics were categorized using the World Health Organization AWaRe framework (2023). Data on indications, number of prescriptions, and individual agents were collected; documentation practices and compliance with AMS recommendations were audited.
Out of 812 total admissions during the study period, 278 patients (34.2%) received one or more systemic antibiotics and were enrolled. The cohort included 205 obstetric and 73 gynaecological inpatients, who together generated 636 antibiotic prescriptions, an average of 2.29 prescriptions per patient.
Surgical prophylaxis was the most frequently documented indication, accounting for 213 prescriptions (33.5%). However, documentation was poor overall: 65.1% of antibiotic prescriptions had no documented clinical indication.
Measured consumption was substantial. The combined DDD per 1,000 patient-days was reported as 1,758.6. The DOT per 1,000 patient-days was 1,852.7. Total patient-days used in these denominators were 821. These metrics indicate a high intensity of antibiotic exposure among the sampled inpatients.
Using the WHO AWaRe framework, 53.6% of prescriptions were classified as Access-group antibiotics and 46.1% as Watch-group antibiotics. The source did not provide a detailed Reserve-group breakdown.
Two agents predominated: ceftriaxone accounted for 38.4% of prescriptions and metronidazole for 36.8%. Combined, these two drugs represented 75.2% of all antibiotic prescriptions in the study population.
Daily AMS rounds by an Infectious Diseases physician and pharmacist were part of the study design to audit ongoing prescribing. Despite the audit activity, measured AMS compliance was 0%, indicating that none of the stewardship recommendations or required documentation standards were met during the study interval.
This observational audit documents a high antibiotic prescribing burden in OBGYN inpatients at a public sector tertiary hospital, with a mean of over two prescriptions per treated patient and high DDD and DOT rates per 1,000 patient-days. The predominance of ceftriaxone and metronidazole and the near-equal split between AWaRe Access and Watch groups highlight reliance on broad-spectrum agents frequently associated with resistance selection pressure.
Crucially, documentation failures were widespread: nearly two-thirds of prescriptions lacked any recorded indication. This undermines basic stewardship practices such as indication-based review, de-escalation, duration control, and targeted therapy. The reported 0% AMS compliance despite daily stewardship rounds points to structural or operational barriers to implementing stewardship recommendations in this setting.
The authors interpret these findings as evidence of urgent institutional need: development and implementation of OBGYN-specific antibiotic guidelines, improved prescription documentation, and structured AMS programs—particularly those that are pharmacist-led—are recommended to close identified gaps.
The study concludes that OBGYN inpatients in this Karachi tertiary hospital experienced a high burden of antibiotic exposure, poor documentation of indications, predominant prescribing of agents with Watch-group representation, and complete failure to meet AMS compliance metrics during the audit period. The authors recommend establishing institutional OBGYN antibiotic guidelines and a structured, pharmacist-led AMS program to improve prescribing practices and reduce stewardship gaps.
The source reports that this preprint has not been peer-reviewed. Ethical approval was obtained from the Institutional Review Board of Dow University of Health Sciences (IRB reference: IRB-/DUHS/Approval/2024/102), and written informed consent was secured from participants; data were anonymized before analysis. The manuscript states the authors declared no competing interests. The source did not provide additional detail on Reserve-group prescriptions or reasons for zero AMS compliance beyond the reported audit findings.